Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:43
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:41
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:40
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:38
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:37
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:32
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:31
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:29
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:27
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:26
Turning Point Therapeutics | 4:持股变动声明
2022/08/18 04:23
Turning Point Therapeutics | 4:持股变动声明
2022/07/30 04:18
Turning Point Therapeutics | 4:持股变动声明
2022/06/02 05:02
Turning Point Therapeutics | 3:首次持股声明-高管 Sabus Steve M
2022/06/02 04:59
Turning Point Therapeutics | 4:持股变动声明
2022/04/13 06:46
Turning Point Therapeutics | 3:首次持股声明-高管 Sun Brian
2022/04/13 06:44
Turning Point Therapeutics | SC 13G:超过5%持股股东披露文件-Cormorant Asset Management, LP(6.11%),Bihua Chen(6.11%)等
2022/02/15 04:02
Turning Point Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(7.7%)
2022/02/15 03:35
Turning Point Therapeutics | 4:持股变动声明
2022/02/12 07:11
Turning Point Therapeutics | 4:持股变动声明
2022/02/12 07:10
暂无数据
暂无数据